GLP-2 TIRZ (Tirzepatide)
Also known as: Tirzepatide, LY3298176, GLP-2 TIRZ
Molecular Overview
Tirzepatide (catalogued as GLP-2 TIRZ) is a dual GIP and GLP-1 receptor agonist peptide. It is significant in metabolic research as a tool for studying combined incretin-receptor pharmacology.
Mechanistic Background
Co-agonism at GIP and GLP-1 receptors activates incretin signalling pathways central to metabolic research.
What Researchers Study
Research has examined GIP/GLP-1 receptor pharmacology and metabolic endpoints.
Evidence Landscape
Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Educational reference only; not a treatment recommendation. Research preparations may differ from clinical-grade material.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.